Wanbangde announced that its wholly-owned subsidiary, Wanbangde Pharmaceutical Group Co., Ltd., has recently received the approval notice for the supplementary application for pharmaceutical registration regarding chlorpromazine hydrochloride tablets issued by the National Medical Products Administration. This pharmaceutical has passed the consistency evaluation of generic drug quality and efficacy, and is the first in the country to do so. The company will accelerate the market promotion of this pharmaceutical, which will have a positive impact on the company's operation and development.